About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
IOVA - Iovance Biotherapeut...| Previous Close | $31.72 | Open | $31.52 |
| Volume | 1.34M | Market Cap | 4.645B |
| Yield | Last Dividend |
| Iovance Biotherapeutics, Inc. (NASDAQ:IO... | 06/25/20 |
| Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) $IOVA #Stocks #biopharmaceutical #MedicalStocks #Healthcarenews Buy at $23, Sell at $47 IOVA???s tumour in... | |
| Why Is Iovance Biotherapeutics (IOVA) Do... | 06/04/20 |
| Iovance Biotherapeutics (IOVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| Iovance Biotherapeutics (IOVA) Upgraded ... | 06/02/20 |
| Iovance Biotherapeutics (IOVA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #... | |
| Iovance (IOVA) Q1 Loss Wider Than Expect... | 05/06/20 |
| Iovance's (IOVA) first-quarter loss wider than estimated. The company progressing well with its lead pipeline candidates. | |
| Do Options Traders Know Something About ... | 04/17/20 |
| Investors need to pay close attention to Iovance Biotherapeutics (IOVA) stock based on the movements in the options market lately. | |
| Iovance Biotherapeutics Inc (NASDAQ:IOVA... | 11/07/19 |
| Brokerages expect that Iovance Biotherapeutics Inc (NASDAQ:IOVA) will announce ($0.42) earnings per share for the current fiscal quarter, Zacks report... | |
| The Daily Biotech Pulse: Positive Readou... | 06/19/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks Hitting 52-week highs on June 18) ... | |
| The Daily Biotech Pulse: Lilly Reports P... | 06/11/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 10) ... | |
| Iovance up 2% premarket on updated TIL d... | 05/31/19 |
| No summary available. | |
| Iovance to build new facility for tumor ... | 05/29/19 |
| No summary available. | |
| Health Care Sector Update for 05/23/2019... | 05/23/19 |
| Top Health Care StocksTop Health Care Stocks JNJ 0 06 JNJ 0 06 PFE 0 61 PFE 0 61 ABT 1 01 ABT 1 01 MRK 0 31 MRK 0 31 AMGN 0 20 AMGN 0 20 Health care s... | |
| Iovance Bio's LN-145 nabs accelerated re... | 05/22/19 |
| No summary available. | |
| Iovance Biotherapeutics: Updating The In... | 05/18/19 |
| No summary available. | |
| 63 Biggest Movers From Yesterday | 05/17/19 |
| Gainers Jiayin Group Inc. (NASDAQ: JFIN) shares rose 56.1 percent to close at $21.70 on Thursday. Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) shares ... | |
| Iovance Biotherapeutics leads healthcare... | 05/16/19 |
| No summary available. | |
| Iovance up 28% premarket on positive TIL... | 05/16/19 |
| No summary available. | |
| Iovance Biotherapeutics Announces Update... | 05/15/19 |
| Patients with advanced cervical cancer treated with LN-145 had an objective response rate of 44 percent Patients in Cohort 2 with advanced melanoma tr... | |
| Iovance Biotherapeutics, Inc. (IOVA) Q1 ... | 05/08/19 |
| IOVA earnings call for the period ending March 31, 2019. | |
| Iovance Biotherapeutics' (IOVA) Manageme... | 05/07/19 |
| Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2019 Earnings Conference Call May 7, 2019 4:30 PM ET Company Participants Tim Morris ??? Chief Financia... | |
| Iovance Biotherapeutics misses by $0.01 | 05/07/19 |
| Iovance Biotherapeutics (IOVA): Q1 GAAP EPS of -$0.30 misses by $0.01. Revenue of $440.02M (-6.1% Y/Y) Press Release | |
| Iovance Biotherapeutics (IOVA) Shares Cr... | 04/03/19 |
| In trading on Wednesday shares of Iovance Biotherapeutics Inc Symbol IOVA crossed above their 200 day moving average of 11 30 changing hands as high a... | |
| Iovance Bio up 6% on pipeline update | 04/03/19 |
| No summary available. | |
| Iovance Biotherapeutics EPS in-line | 02/27/19 |
| No summary available. | |
| Iovance Bio's LN-145 Fast Track'd for ce... | 02/26/19 |
| No summary available. | |
| FDA finalizes guidance for expedited rev... | 02/15/19 |
| No summary available. | |
| Iovance Biotherapeutics (IOVA) Investor ... | 01/11/19 |
| No summary available. | |
| Iovance Biotherapeutics (IOVA) Investor ... | 01/11/19 |
| No summary available. | |
| Iovance Biotherapeutics (IOVA) Presents ... | 01/11/19 |
| No summary available. | |
| Buy rating | 08/07/20 |
| Chardan Capital maintains Buy rating and raises Price Target from $44.00 to $53.00 | |
| Date | 2020-08-06 (AMC) | Est. (EPS/Rev.) | ($0.53)/ 0 |
| Actual (EPS/Rev.) | $-0.47/ | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Biotechnology | Robert Gadimian | 26.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
